Loading...
OTC Markets
Totals
Securities
12,306
Dollar Vol
$1.9B
Share Vol
3.9B
Trades
350,584

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

CANN
TREES Corporation

Common Stock

0.02581

0.00128

5.22%

0.0253 / 0.027 (1 x 1)

Real-Time Best Bid & Ask: 04:25pm 07/11/2025
Delayed (15 Min) Trade Data: 03:14pm 07/11/2025
OTC Disclosure & News Service

GAITHERSBURG, Md., Feb. 02, 2018 (GLOBE NEWSWIRE) -- General Cannabis Corp. (OTCQB:CANN) today announced that its client, Green Leaf Medical LLC, a leading grower and supplier of medical cannabis in Maryland, has successfully harvested its first crop and has passed all state-required laboratory tests. Now producing an estimated 500-600 pounds of high-quality medical marijuana on a monthly basis, Green Leaf is one of the leading fully approved suppliers in Maryland.

Green Leaf  also announced that it has begun the next phase of its expansion, increasing the size of its facility to approximately 50,000 square feet, a 67 percent increase from current capacity. The expanded grow house should be completed before the end of the year, raising production totals to nearly 1,000 pounds per month.

“From the outset, Green Leaf worked with Next Big Crop to help design and build its state-of-the-art grow facility, and to establish rigorous operational procedures, ensuring the highest quality product for Maryland patients,” said Richard Cardinal, managing director of Next Big Crop. “Our operational model is most effective when we are are able to participate in each phase of the planning, building and management of these facilities. Green Leaf’s success is a great example of that.”

Philip Goldberg, CEO of Green Leaf Medical, added: “Our commitment to meeting pharmaceutical manufacturing standards combined with Next Big Crop’s established operational protocol and oversight helped us achieve this level of productivity in just four months of operation.”

“Next Big Crop’s consulting success in Maryland reflects the growing national presence, reputation and strategy of General Cannabis,” according to Robert Frichtel, Chief Executive Officer of General Cannabis. “We recently signed several new contracts in California and we are expanding our business opportunities in Arizona.”

About General Cannabis Corp.
General Cannabis Corp. is the comprehensive national resource for the highest-quality service providers available to the regulated cannabis industry. We are a trusted partner to the cultivation, production and retail sides of the cannabis business. We do this through a combination of strong operating divisions such as security, marketing, operational consulting and products, real estate and financing. As a synergistic holding company, our divisions are able to leverage the strengths of each other, as well as a larger balance sheet, to succeed. Our website address is www.generalcann.com.

Forward-looking Statements
This release contains forward-looking statements that relate to future events or General Cannabis’ future performance or financial condition. Such statements include statements regarding the expansion of the Green Leaf grow house and increasing its production totals; statements regarding Next Big Crop’s anticipated expansion in California and Arizona;  and statements regarding the growing national presence, reputation, and strategy of Next Big Crop.   

Any statements that are not statements of historical fact, such as the statements above and including statements containing the words “plans,” “anticipates,” “expects” and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in General Cannabis’ filings with the Securities and Exchange Commission. General Cannabis undertakes no duty to update any forward-looking statements made herein.

Contact
Robert Frichtel
CEO, General Cannabis Corp
(303) 759-1300

Primary Logo

The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Limited Information Icon
Pink Limited Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.